Acute In Vivo Administration of Compound 21 Stimulates Akt and ERK1/2 Phosphorylation in Mouse Heart and Adipose

Diego T Quiroga1, Jorge A Narvaéz Pardo1, María G Zubiría2

  • 1Facultad de Farmacia y Bioquímica, Departamento de Química Biológica and IQUIFIB (UBA-CONICET), Universidad de Buenos Aires, Buenos Aires C1113AAD, Argentina.

Insights

The angiotensin II type 2 (AT2) receptor agonist C21 activates key insulin signaling molecules Akt and ERK1/2 in mice. This activation occurs independently of the insulin receptor (IR), suggesting novel pathways for improved insulin sensitivity.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • The angiotensin II type 2 (AT2) receptor is implicated in enhancing insulin sensitivity.
  • The precise molecular mechanisms of AT2 receptor-mediated insulin facilitation remain unclear.

Purpose of the Study:

  • To determine if acute in vivo administration of the AT2 receptor agonist C21 activates insulin signaling pathways in target tissues.
  • To elucidate the role of the insulin receptor (IR) in AT2 receptor-induced signaling.

Main Methods:

  • Acute intravenous injection of C21 (0.25 mg/kg) in male C57BL/6 mice.
  • Analysis of Akt and ERK1/2 phosphorylation in epididymal white adipose tissue (WAT) and heart tissue.
  • Assessment of insulin receptor (IR) phosphorylation levels.

Main Results:

  • C21 induced significant phosphorylation of Akt and ERK1/2 in both WAT and heart.
  • C21-mediated phosphorylation of Akt and ERK1/2 in WAT was substantial, reaching ~65% of insulin-induced levels.
  • C21 stimulated p-Akt in the heart to a lesser extent than in WAT, and p-ERK1/2 to levels comparable to insulin.
  • Crucially, C21 did not alter insulin receptor (IR) phosphorylation in either tissue.

Conclusions:

  • Acute in vivo administration of the AT2 receptor agonist C21 activates Akt and ERK1/2 signaling.
  • This activation proceeds through a mechanism independent of the insulin receptor (IR).
  • These findings highlight the involvement of Akt and ERK1/2 in AT2 receptor-mediated signaling pathways relevant to insulin sensitivity.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K